Income Statement (TTM)
C4 Therapeutics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33 | 33 | 34 | 34 | 34 | 46 | 46 | 50 | 48 | 31 | 27 | 16 | 20 | 21 | 20 | 29 | 34 | 36 | 40 | 34 |
| Change (%) | 0.16 | 1.84 | 0.33 | 0.16 | 34.78 | 0.50 | 8.81 | -3.49 | -35.65 | -12.53 | -41.06 | 26.94 | 2.00 | -3.47 | 46.63 | 14.60 | 5.69 | 11.80 | -13.93 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 74 | 77 | 82 | 87 | 88 | 95 | 100 | 108 | 114 | 118 | 121 | 119 | 118 | 118 | 111 | 105 | 109 | 111 | 115 | 118 |
| Change (%) | 4.65 | 5.44 | 6.77 | 0.42 | 8.10 | 6.00 | 8.01 | 4.95 | 3.61 | 2.41 | -1.16 | -1.10 | -0.22 | -5.53 | -5.55 | 3.32 | 1.96 | 4.10 | 2.12 | |
| % of Revenue | 223.35 | 233.37 | 241.63 | 257.13 | 257.81 | 206.76 | 218.07 | 216.47 | 235.39 | 378.96 | 443.66 | 744.08 | 579.72 | 567.09 | 554.99 | 357.49 | 322.31 | 310.92 | 289.51 | 343.52 |
| Gross Operating Profit | -41 | -44 | -48 | -53 | -54 | -49 | -54 | -58 | -65 | -87 | -93 | -103 | -98 | -97 | -91 | -76 | -75 | -75 | -75 | -83 |
| Change (%) | 8.29 | 8.14 | 11.31 | 0.59 | -8.82 | 11.15 | 7.33 | 12.19 | 32.60 | 7.76 | 10.45 | -5.46 | -0.68 | -5.97 | -17.02 | -1.06 | 0.28 | 0.45 | 10.59 | |
| % of Revenue | -123.35 | -133.37 | -141.63 | -157.13 | -157.81 | -106.76 | -118.07 | -116.47 | -135.39 | -278.96 | -343.66 | -644.08 | -479.72 | -467.09 | -454.99 | -257.49 | -222.31 | -210.92 | -189.51 | -243.52 |
| SG&A | 11 | 15 | 20 | 26 | 31 | 33 | 39 | 40 | 41 | 43 | 41 | 41 | 42 | 42 | 41 | 41 | 42 | 42 | 41 | 40 |
| Change (%) | 36.20 | 30.04 | 29.55 | 21.83 | 6.57 | 16.27 | 3.32 | 2.82 | 4.17 | -4.38 | 1.00 | 2.31 | -0.47 | -1.56 | -1.47 | 3.03 | 0.18 | -2.27 | -2.25 | |
| % of Revenue | 33.68 | 45.80 | 58.49 | 75.52 | 91.86 | 72.63 | 84.03 | 79.79 | 85.01 | 137.60 | 150.41 | 257.78 | 207.77 | 202.74 | 206.75 | 138.92 | 124.89 | 118.38 | 103.48 | 117.52 |
| R&D | 1 | 1 | 1 | 1 | ||||||||||||||||
| Change (%) | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| % of Revenue | 2.93 | 2.88 | 2.87 | 2.86 | ||||||||||||||||
| OpEx | 85 | 94 | 102 | 114 | 120 | 128 | 139 | 148 | 155 | 161 | 162 | 161 | 160 | 160 | 153 | 146 | 151 | 153 | 156 | 158 |
| Change (%) | 9.93 | 9.38 | 11.10 | 5.24 | 6.82 | 8.67 | 6.71 | 4.37 | 3.76 | 0.60 | -0.61 | -0.23 | -0.29 | -4.48 | -4.44 | 3.24 | 1.46 | 2.34 | 0.97 | |
| % of Revenue | 257.04 | 282.10 | 302.99 | 335.51 | 352.53 | 279.39 | 302.10 | 296.26 | 320.40 | 516.56 | 594.07 | 1,001.86 | 787.49 | 769.84 | 761.73 | 496.42 | 447.20 | 429.30 | 392.99 | 461.03 |
| Operating Income | -52 | -60 | -69 | -80 | -86 | -82 | -93 | -98 | -106 | -130 | -134 | -145 | -140 | -139 | -133 | -116 | -117 | -117 | -117 | -124 |
| Change (%) | 16.15 | 13.52 | 16.40 | 7.39 | -4.25 | 13.22 | 5.66 | 8.38 | 21.63 | 3.75 | 7.58 | -3.24 | -0.62 | -4.64 | -12.16 | 0.37 | 0.24 | -0.53 | 6.06 | |
| % of Revenue | -157.04 | -182.10 | -202.99 | -235.51 | -252.53 | -179.39 | -202.10 | -196.26 | -220.40 | -416.56 | -494.07 | -901.86 | -687.49 | -669.84 | -661.73 | -396.42 | -347.20 | -329.30 | -292.99 | -361.03 |
| Interest Expense | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -0 | 0 | |||
| Change (%) | 78.37 | 43.45 | 23.03 | -1.06 | -0.05 | -0.33 | 0.05 | 0.70 | 2.88 | 3.56 | 2.88 | -16.39 | -30.45 | -44.14 | -78.23 | -100.00 | ||||
| % of Revenue | -2.08 | -3.70 | -5.22 | -6.40 | -6.32 | -4.68 | -4.65 | -4.27 | -4.46 | -7.13 | -8.44 | -14.73 | -9.70 | -6.61 | -3.83 | -0.57 | 0.00 | |||
| Net Income | -55 | -66 | -75 | -87 | -90 | -84 | -95 | -99 | -107 | -128 | -131 | -140 | -135 | -132 | -126 | -108 | -105 | -105 | -103 | -112 |
| Change (%) | 21.58 | 13.66 | 15.63 | 3.27 | -6.82 | 12.69 | 5.11 | 7.32 | 20.19 | 2.47 | 6.48 | -3.52 | -1.80 | -4.84 | -14.44 | -2.20 | -0.17 | -1.94 | 8.04 | |
| % of Revenue | -164.63 | -199.83 | -223.03 | -257.05 | -265.03 | -183.23 | -205.47 | -198.48 | -220.71 | -412.19 | -482.83 | -872.34 | -663.05 | -638.34 | -629.24 | -367.17 | -313.35 | -295.96 | -259.60 | -325.88 |
Source: Capital IQ
